Bar Coding Should Begin With Eight “High Priority” Products, HDMA Says
Executive Summary
The Healthcare Distribution Management Association is recommending that eight "high-risk, high-priority" drugs be the first targets for bar coding
You may also be interested in...
FDA Bar Coding Final Rule Sets Two-Year Implementation Timeline
FDA's pharmaceutical bar coding final rule has a shorter implementation timeline than the agency previously proposed
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials